Trestle Biotherapeutics
PrivateLast Round
Grant
Jun 12, 2023
Est. Valuation
$1.79M
Total Funding Raised
$1.13M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Trestle Biotherapeutics is a biotechnology company that develops bioengineered kidney tissues to treat patients with end-stage renal disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trestle Biotherapeutics Comparables
Compare Trestle Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellite Bio | 82% | |
| Rege Nephro Co., Ltd. | 79% | |
| LiveKidney.BIO | 79% |
Trestle Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2023 | ||||
| Accelerator | Jan 5, 2021 |
Trestle Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
| Kidney Innovation Accelerator | Grant |
| C3 Ventures | Accelerator |
| Black Mountain Ventures | Accelerator |
| Formic Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 273% MoM, reaching 4.4K.
- Jun 21, 2026
Monthly visitors grew 48% MoM.
Trestle Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Trestle Biotherapeutics's valuation, stock price, and market status.
Is Trestle Biotherapeutics a public or private company?
Trestle Biotherapeutics is a private company.
What is the current stock price of Trestle Biotherapeutics?
Trestle Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Trestle Biotherapeutics worth (valuation)?
Trestle Biotherapeutics's valuation is estimated at $1.8M based on funding round data.
Can I buy Trestle Biotherapeutics stock?
Trestle Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Trestle Biotherapeutics's last funding round?
Trestle Biotherapeutics's most recent funding round was Grant on January 5, 2021.
Who are the main investors in Trestle Biotherapeutics?
Key investors in Trestle Biotherapeutics include Y Combinator.
Will Trestle Biotherapeutics IPO soon?
No public IPO plans have been announced for Trestle Biotherapeutics.
How can I track Trestle Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trestle Biotherapeutics's secondary market activity and sign up for updates.